Europhartech Implements Fully Integrated Pharmaceutical Serialization in Compliance with 2019 EU Regulations

The EU Falsified Medicines Directive required pharmaceutical manufacturers to serialize individual product units — assigning, verifying, and reporting unique identifiers at the item level — by February 2019. Europhartech faced a non-negotiable regulatory deadline with no tolerance for delay: missed compliance would mean halted shipments and potential product withdrawal from European markets. The core technical challenge was not simply installing new serialization hardware but achieving deterministic, validated integration between existing line-level packaging automation and an enterprise serialization platform, all within a compressed project timeline that left little room for iterative troubleshooting.

Rockwell Automation, working alongside system integrator H2M Technologies, deployed a fully integrated automation and serialization stack built around a unified control architecture. At the line level, a ControlLogix Programmable Automation Controller (PAC) coordinated motion across six Kinetix 5500 servo drives, delivering the precise, repeatable packaging sequences required for accurate item-level marking and labeling. Operators interact with the line through a VersaView industrial computer running FactoryTalk View SE, providing a consistent HMI layer across the production environment. The enterprise serialization layer runs on Rockwell's PharmaSuite MES serialization module, managing serial number pools, aggregation hierarchies, and regulatory data reporting. By centering the architecture on the ControlLogix PAC, the implementation achieved tight, deterministic communication between line control and the MES — eliminating the integration gaps that commonly arise in multi-vendor serialization deployments and compressing the validation and commissioning cycle.

Europhartech brought the system online on time and on budget, meeting the February 2019 EU FMD deadline without disrupting ongoing production schedules. The installation achieved full legislative compliance for pharmaceutical serialization across the packaging line, satisfying regulatory requirements for unique identifier issuance, verification, and audit reporting. Beyond compliance, the PAC-centric architecture delivered practical operational improvements:

• On-time regulatory compliance — system operational before the February 2019 enforcement date
• Simplified commissioning and maintenance — unified control architecture reduced integration touchpoints versus multi-vendor alternatives
• Future-ready design — aggregation capability built into the architecture, enabling expansion without redesigning existing line control or MES configuration

• A PAC-based serialization architecture that tightly couples line-level automation with the MES reduces validation complexity and eliminates the compliance gaps common in loosely integrated systems.
• Pre-compliance serialization projects leave no room for phased discovery — solution stacks should be pre-validated and proven before site deployment begins.
• Designing for aggregation from the outset avoids costly rework as regulatory requirements evolve beyond item-level serialization.
• Engaging a specialist system integrator (H2M Technologies) alongside the OEM (Rockwell Automation) accelerates site-specific adaptation without compromising the validated solution architecture.